According to filings with the U.S. Securities and Exchange Commission, Spineology Inc. is raising up to $10,522,826.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About Spineology Inc.
Spineology’s OptiMesh is the only conforming, patient specific lumbar expandable implant on the market. OptiMesh is delivered through the smallest insertion profile, dynamically conforms to a patients unique endplate morphology, and powerfully expands to one of the largest implant footprints available. Spineologys OptiMesh features our unique Conform and Expand technology, enabling a custom anatomical fit for lumbar fusion surgical patients. OptiMesh is designed to overcome the challenges of static and mechanically expandable implants.

To learn more about Spineology Inc., visit https://spineology.com/
Spineology Inc. Linkedin Page: https://www.linkedin.com/company/spineology-inc-/

Contact:
Steve Nemitz, Chief Financial Officer
651-351-1011

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.